The effect of tenoxicam on tolbutamide pharmacokinetics and glucose concentrations in healthy volunteers

Int J Clin Pharmacol Ther. 1995 May;33(5):308-10.

Abstract

There was no significant difference in the pharmacokinetic parameters of tolbutamide (500 mg) determined before and after 14 days treatment with tenoxicam (20 mg/day) in 7 healthy volunteers (6 male, 1 female). In addition, co-administration of tenoxicam did not alter blood glucose concentrations.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Analysis of Variance
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Blood Glucose / metabolism*
  • Chromatography, High Pressure Liquid
  • Computer Simulation
  • Drug Interactions
  • Female
  • Humans
  • Male
  • Middle Aged
  • Piroxicam / administration & dosage
  • Piroxicam / analogs & derivatives*
  • Piroxicam / pharmacology
  • Tolbutamide / administration & dosage
  • Tolbutamide / blood
  • Tolbutamide / pharmacokinetics*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Blood Glucose
  • Piroxicam
  • Tolbutamide
  • tenoxicam